These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
423 related articles for article (PubMed ID: 27080243)
1. Refractory and super-refractory status epilepticus in adults: a 9-year cohort study. Delaj L; Novy J; Ryvlin P; Marchi NA; Rossetti AO Acta Neurol Scand; 2017 Jan; 135(1):92-99. PubMed ID: 27080243 [TBL] [Abstract][Full Text] [Related]
2. Determinants and predictors of outcome in super refractory status epilepticus--a developing country perspective. Jayalakshmi S; Ruikar D; Vooturi S; Alladi S; Sahu S; Kaul S; Mohandas S Epilepsy Res; 2014 Nov; 108(9):1609-17. PubMed ID: 25246354 [TBL] [Abstract][Full Text] [Related]
3. Factors associated with occurrence and outcome of super-refractory status epilepticus. Madžar D; Knappe RU; Reindl C; Giede-Jeppe A; Sprügel MI; Beuscher V; Gollwitzer S; Hamer HM; Huttner HB Seizure; 2017 Nov; 52():53-59. PubMed ID: 28963934 [TBL] [Abstract][Full Text] [Related]
4. Long-term outcome of refractory status epilepticus in adults: A retrospective population-based study. Kantanen AM; Reinikainen M; Parviainen I; Kälviäinen R Epilepsy Res; 2017 Jul; 133():13-21. PubMed ID: 28402834 [TBL] [Abstract][Full Text] [Related]
5. Incidence and mortality of super-refractory status epilepticus in adults. Kantanen AM; Reinikainen M; Parviainen I; Ruokonen E; Ala-Peijari M; Bäcklund T; Koskenkari J; Laitio R; Kälviäinen R Epilepsy Behav; 2015 Aug; 49():131-4. PubMed ID: 26141934 [TBL] [Abstract][Full Text] [Related]
6. Incidence of the different stages of status epilepticus in Eastern Finland: A population-based study. Kantanen AM; Sairanen J; Kälviäinen R Epilepsy Behav; 2019 Dec; 101(Pt B):106413. PubMed ID: 31371204 [TBL] [Abstract][Full Text] [Related]
7. Super-refractory status epilepticus in West China. Tian L; Li Y; Xue X; Wu M; Liu F; Hao X; Zhou D Acta Neurol Scand; 2015 Jul; 132(1):1-6. PubMed ID: 25314275 [TBL] [Abstract][Full Text] [Related]
8. Costs, length of stay, and mortality of super-refractory status epilepticus: A population-based study from Germany. Strzelczyk A; Ansorge S; Hapfelmeier J; Bonthapally V; Erder MH; Rosenow F Epilepsia; 2017 Sep; 58(9):1533-1541. PubMed ID: 28681418 [TBL] [Abstract][Full Text] [Related]
9. Vagus nerve stimulation in refractory and super-refractory status epilepticus - A systematic review. Dibué-Adjei M; Brigo F; Yamamoto T; Vonck K; Trinka E Brain Stimul; 2019; 12(5):1101-1110. PubMed ID: 31126871 [TBL] [Abstract][Full Text] [Related]
10. A one-year prospective study of refractory status epilepticus in Modena, Italy. Giovannini G; Monti G; Polisi MM; Mirandola L; Marudi A; Pinelli G; Valzania F; Girardis M; Nichelli PF; Meletti S Epilepsy Behav; 2015 Aug; 49():141-5. PubMed ID: 26074182 [TBL] [Abstract][Full Text] [Related]
11. Refractory status epilepticus: a prospective observational study. Novy J; Logroscino G; Rossetti AO Epilepsia; 2010 Feb; 51(2):251-6. PubMed ID: 19817823 [TBL] [Abstract][Full Text] [Related]
12. Pediatric refractory and super-refractory status epilepticus. Vasquez A; Farias-Moeller R; Tatum W Seizure; 2019 May; 68():62-71. PubMed ID: 29941225 [TBL] [Abstract][Full Text] [Related]
13. Status epilepticus: Refractory and super-refractory. Dubey D; Kalita J; Misra UK Neurol India; 2017; 65(Supplement):S12-S17. PubMed ID: 28281491 [TBL] [Abstract][Full Text] [Related]
14. Specific characteristics and current diagnostic and treatment modalities performance of super refractory status epilepticus in children: A comparative study. Briassoulis G; Stefanogianni C; Zaganas I; Raissaki M; Briassoulis P; Ilia S Eur J Paediatr Neurol; 2022 Mar; 37():32-39. PubMed ID: 35051734 [TBL] [Abstract][Full Text] [Related]
15. Determinants of mortality and long-term outcome in children with refractory and super refractory status epilepticus. Jayalakshmi S; Patil A; Challa A; Parekh M; Khandelia H; Vooturi S J Clin Neurosci; 2022 Mar; 97():12-16. PubMed ID: 35030458 [TBL] [Abstract][Full Text] [Related]
16. Efficacy and safety of perampanel in refractory and super-refractory status epilepticus: cohort study of 81 patients and literature review. Lim SN; Wu T; Tseng WJ; Chiang HI; Cheng MY; Lin WR; Lin CN J Neurol; 2021 Oct; 268(10):3744-3757. PubMed ID: 33754209 [TBL] [Abstract][Full Text] [Related]
17. Burden and epidemiology of status epilepticus in infants, children, and adolescents: A population-based study on German health insurance data. Schubert-Bast S; Zöllner JP; Ansorge S; Hapfelmeier J; Bonthapally V; Eldar-Lissai A; Rosenow F; Strzelczyk A Epilepsia; 2019 May; 60(5):911-920. PubMed ID: 30980677 [TBL] [Abstract][Full Text] [Related]
18. Use of perampanel oral suspension for the treatment of refractory and super-refractory status epilepticus. Bruschi G; Pellegrino L; Bisogno AL; Ferreri F; Kassabian B; Seppi D; Favaretto S; Corbetta M; Dainese F Epilepsy Behav; 2024 Jul; 156():109826. PubMed ID: 38761446 [TBL] [Abstract][Full Text] [Related]
19. How much refractory is 'refractory status epilepticus'? A retrospective study of treatment strategies and clinical outcomes. Lattanzi S; Giovannini G; Orlandi N; Brigo F; Trinka E; Meletti S J Neurol; 2023 Dec; 270(12):6133-6140. PubMed ID: 37587268 [TBL] [Abstract][Full Text] [Related]
20. [Effectiveness of ketamine in the treatment of refractory and super-refractory status epilepticus in children]. Wu J; Wang Q; Qian SY; Gao HM; Liu J; Deng J; Zeng JS Zhonghua Er Ke Za Zhi; 2020 Apr; 58(4):295-300. PubMed ID: 32234136 [No Abstract] [Full Text] [Related] [Next] [New Search]